JAAD 03/23 Risk of melanoma and nonmelanoma skin cancer with immunosuppressants. Part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors

false

Medicine Without Barriers

Image For Activity Cover

JAAD 03/23 Risk of melanoma and nonmelanoma skin cancer with immunosuppressants. Part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors

Summary


Availability:	On-Demand
	Expires on Mar 31, 2026


Credit Offered:	1 CME Credit 4 CCP-SA Points

Legal notice
Copyright © 2023 American Academy of Dermatology. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.

Powered By